forgot to take my semaglutide shot Woman shares what happened after she stopped taking This post isn't about fear.

Food and Drug Administration (FDA) announced that theyve cleared the first generic GLP-1 injectable to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise. This language likely means that the drug will be available only to diabetics, in contrast to some of the name-brand medications in this class which have been approved for some weight loss cases

Breaking News: Oral Wegovy Pill Approved (December 2025) On December 22, 2025 , the FDA approved a pill version of Wegovy , marking a significant milestone as the first daily oral medication for obesity

To stay safe, consult a healthcare provider about these risks

Stroke risk in women: the role of menopause and hormone therapy

Another lever available to employers to manage costs is to limit GLP-1 reimbursement to employees

Countless women and men have now made the switch to bio-identical hormones long preferred for hormone therapy in Japan, France and other European countries